Stay updated on Safety of HSC835 in Hematological Malignancies Clinical Trial
Sign up to get notified when there's something new on the Safety of HSC835 in Hematological Malignancies Clinical Trial page.

Latest updates to the Safety of HSC835 in Hematological Malignancies Clinical Trial page
- Check7 days agoChange DetectedAdded three disease terms—Burkitt lymphoma, B-cell chronic lymphocytic leukemia, and acute lymphoid leukemia—to the study's keywords/MeSH terms to broaden indexing and searchability.SummaryDifference0.2%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedSite revision updated to v3.5.0, replacing the previous v3.4.3.SummaryDifference0.1%

- Check28 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check57 days agoChange DetectedRevision label updated to v3.4.2 and the previous notices about funding and operating status were removed. These changes are minor and do not affect study details or access to information; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check64 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and NIH Clinical Center operating status, with guidance to visit cc.nih.gov and opm.gov for updates. Updated the system revision from Revision: v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check71 days agoChange DetectedGlossary feature added and minor typography changes (capitalization of labels in QC criteria) plus new No FEAR Act Data and a site revision indicator (v3.4.0) appear on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Safety of HSC835 in Hematological Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of HSC835 in Hematological Malignancies Clinical Trial page.